tiprankstipranks
Emergent Biosolutions (EBS)
NYSE:EBS
US Market
EBS
Emergent Biosolutions
RESEARCH TOOLSreports
Want to see EBS full AI Analyst Report?

Emergent Biosolutions (EBS) Ratios

1,361 Followers

Emergent Biosolutions Ratios

EBS's free cash flow for Q1 2026 was $0.43. For the 2026 fiscal year, EBS's free cash flow was decreased by $ and operating cash flow was $0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.29 5.01 3.69 1.04 0.98
Quick Ratio
 2.08 2.41 1.77 0.54 0.70
Cash Ratio
 1.08 1.55 0.61 0.17 0.52
Solvency Ratio
 0.11 0.19 -0.09 -0.54 -0.05
Operating Cash Flow Ratio
 1.00 1.29 0.36 -0.32 -0.03
Short-Term Operating Cash Flow Coverage
 0.00 0.00 21.74 -0.50 -0.04
Net Current Asset Value
$ -159.70M$ -133.50M$ -308.20M$ -494.40M$ -568.20M
Leverage Ratios
Debt-to-Assets Ratio
 0.43 0.43 0.49 0.47 0.45
Debt-to-Equity Ratio
 1.10 1.09 1.40 1.32 1.03
Debt-to-Capital Ratio
 0.52 0.52 0.58 0.57 0.51
Long-Term Debt-to-Capital Ratio
 0.52 0.52 0.58 0.41 0.24
Financial Leverage Ratio
 2.52 2.52 2.88 2.81 2.28
Debt Service Coverage Ratio
 2.78 3.01 0.08 -0.15 0.02
Interest Coverage Ratio
 1.28 1.86 -1.53 -8.26 -4.56
Debt to Market Cap
 1.40 0.87 1.32 7.00 2.39
Interest Debt Per Share
 12.12 11.80 14.10 18.52 29.22
Net Debt to EBITDA
 2.48 1.76 10.80 -15.93 49.92
Profitability Margins
Gross Profit Margin
44.44%47.19%35.97%34.31%42.33%
EBIT Margin
10.52%14.83%-5.00%-16.02%-9.78%
EBITDA Margin
24.62%28.07%5.12%-4.48%1.40%
Operating Profit Margin
10.52%14.83%-10.42%-69.23%-15.21%
Pretax Profit Margin
0.52%11.15%-13.69%-69.68%-19.60%
Net Profit Margin
-1.27%7.08%-18.26%-72.48%-18.94%
Continuous Operations Profit Margin
-1.27%7.08%-18.26%-72.48%-18.94%
Net Income Per EBT
-245.71%63.53%133.38%104.01%96.62%
EBT Per EBIT
4.92%75.14%131.46%100.66%128.82%
Return on Assets (ROA)
-0.65%3.99%-13.72%-41.71%-6.68%
Return on Equity (ROE)
-1.59%10.07%-39.48%-117.13%-15.25%
Return on Capital Employed (ROCE)
6.08%9.29%-8.86%-61.98%-8.77%
Return on Invested Capital (ROIC)
-14.93%5.90%-8.84%-45.81%-5.66%
Return on Tangible Assets
-1.01%5.96%-21.46%-60.52%-9.53%
Earnings Yield
-2.09%7.95%-37.62%-618.90%-35.76%
Efficiency Ratios
Receivables Turnover
 5.57 8.82 6.75 5.49 7.02
Payables Turnover
 9.52 7.06 10.97 6.14 6.23
Inventory Turnover
 1.15 1.14 2.14 2.10 1.84
Fixed Asset Turnover
 3.39 3.62 3.86 2.63 1.34
Asset Turnover
 0.51 0.56 0.75 0.58 0.35
Working Capital Turnover Ratio
 1.33 1.54 4.49 216.35 2.55
Cash Conversion Cycle
 345.25 309.14 191.03 181.19 192.00
Days of Sales Outstanding
 65.58 41.37 54.04 66.44 52.00
Days of Inventory Outstanding
 318.02 319.50 170.26 174.16 198.61
Days of Payables Outstanding
 38.34 51.73 33.27 59.41 58.62
Operating Cycle
 383.60 360.87 224.30 240.60 250.61
Cash Flow Ratios
Operating Cash Flow Per Share
 2.85 3.19 1.11 -4.03 -0.68
Free Cash Flow Per Share
 2.61 2.93 0.68 -5.04 -2.99
CapEx Per Share
 0.24 0.26 0.43 1.01 2.31
Free Cash Flow to Operating Cash Flow
 0.91 0.92 0.61 1.25 4.40
Dividend Paid and CapEx Coverage Ratio
 11.75 12.36 2.56 -4.00 -0.29
Capital Expenditure Coverage Ratio
 11.75 12.36 2.56 -4.00 -0.29
Operating Cash Flow Coverage Ratio
 0.26 0.30 0.09 -0.24 -0.02
Operating Cash Flow to Sales Ratio
 0.22 0.23 0.06 -0.20 -0.03
Free Cash Flow Yield
33.05%23.71%7.07%-209.88%-25.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -47.92 12.57 -2.66 -0.16 -2.80
Price-to-Sales (P/S) Ratio
 0.61 0.89 0.49 0.12 0.53
Price-to-Book (P/B) Ratio
 0.79 1.27 1.05 0.19 0.43
Price-to-Free Cash Flow (P/FCF) Ratio
 3.03 4.22 14.15 -0.48 -3.95
Price-to-Operating Cash Flow Ratio
 2.78 3.88 8.63 -0.60 -17.35
Price-to-Earnings Growth (PEG) Ratio
 0.40 -0.10 0.04 >-0.01 0.01
Price-to-Fair Value
 0.79 1.27 1.05 0.19 0.43
Enterprise Value Multiple
 4.94 4.93 20.29 -18.54 87.61
Enterprise Value
 822.97M 1.03B 1.08B 871.38M 1.38B
EV to EBITDA
 4.94 4.93 20.29 -18.54 87.61
EV to Sales
 1.22 1.38 1.04 0.83 1.23
EV to Free Cash Flow
 6.08 6.56 30.26 -3.38 -9.18
EV to Operating Cash Flow
 5.56 6.03 18.45 -4.22 -40.34
Tangible Book Value Per Share
 1.02 1.61 -0.35 1.62 8.80
Shareholders’ Equity Per Share
 10.08 9.77 9.11 12.68 27.70
Tax and Other Ratios
Effective Tax Rate
 3.46 0.36 -0.33 -0.04 0.03
Revenue Per Share
 13.04 13.89 19.69 20.49 22.31
Net Income Per Share
 -0.17 0.98 -3.60 -14.85 -4.22
Tax Burden
 -2.46 0.64 1.33 1.04 0.97
Interest Burden
 0.05 0.75 2.74 4.35 2.00
Research & Development to Revenue
 0.07 0.07 0.07 0.11 0.17
SG&A to Revenue
 0.27 0.25 0.29 0.00 0.00
Stock-Based Compensation to Revenue
 0.02 0.02 0.02 0.02 0.04
Income Quality
 -17.21 3.24 -0.31 0.27 0.16
Currency in USD